EUVIMEDEUVIMED entdecken
Crossref

Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma

Marcella Steffani, Ulrich Nitsche, Johanna Ollesky, Benedikt Kaufmann, Sarah Schulze, Alexander Novotny, Helmut Friess, Norbert Hüser, Christian Stoess, Daniel Hartmann

Digestive Surgery · 2024

DOI: 10.1159/000535733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Surgery, 2024. Verfasst von Marcella Steffani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany, marcella.steffani@tum.de. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cholangiocarcinoma is the second most common primary liver tumour worldwide with an increasing incidence in recent decades. While the effects of fibrosis on hepatocellular carcinoma have been widely demonstrated, the impact on cholangiocarcinoma remains unclear. The aim of this study was to evaluate the impact of liver fibrosis on overall survival (OS) and disease-free survival (DFS) in patients who have undergone liver resection for cholangiocarcinoma.

Methods

Eighty patients with cholangiocarcinoma who underwent curatively intended liver surgery between January 2007 and December 2020 were included in this retrospective single-centre study. Clinical and histopathological features were analysed. The primary endpoint was cause-specific survival. Secondary endpoints were DFS and identification of prognostic factors.

Results

The present study shows that the median OS is significantly reduced in patients with fibrosis (p < 0.001). The median OS in patients with fibrosis was three times shorter than in the group without fibrosis. In addition, a significantly shorter DFS was observed in patients with fibrosis (p < 0.002). Multivariate analysis showed that fibrosis is the strongest independent factor with a negative impact on OS and DFS.

Conclusion

Liver fibrosis has a significant impact on OS and DFS in patients with cholangiocarcinoma. Patients with known liver fibrosis require thorough perioperative care and postoperative follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaCarcinoma, HepatocellularLiver NeoplasmsBile Duct NeoplasmsHumansRetrospective StudiesLiver CirrhosisFibrosisBile Ducts, IntrahepaticPrognosisNeoplasm Recurrence, LocalHepatectomy

Stichwörter der Autor:innen

CholangiocarcinomaLiver fibrosisLiver surgeryOverall survivalRecurrence

Autor:innen und Institutionen

  • Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany, marcella.steffani@tum.de.
  • Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Zitieren

APA

Steffani, M., Nitsche, U., Ollesky, J., Kaufmann, B., Schulze, S., Novotny, A., Friess, H., Hüser, N., Stoess, C., & Hartmann, D. (2024). Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma. Digestive Surgery. https://doi.org/10.1159/000535733

Vancouver

Steffani M, Nitsche U, Ollesky J, Kaufmann B, Schulze S, Novotny A, et al. Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma. Digestive Surgery. 2024. doi:10.1159/000535733

BibTeX
@article{Steffani2024,
  author = {Steffani, Marcella and Nitsche, Ulrich and Ollesky, Johanna and Kaufmann, Benedikt and Schulze, Sarah and Novotny, Alexander and Friess, Helmut and Hüser, Norbert and Stoess, Christian and Hartmann, Daniel},
  title = {Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma},
  journal = {Digestive Surgery},
  year = {2024},
  doi = {10.1159/000535733}
}
Kostenlos starten →